ImproveCareNow (ICN)
To improve patient care and achieve the best health outcomes possible for children with IBD.
To improve patient care and achieve the best health outcomes possible for children with IBD.
To evaluate long-term safety of Humira in pediatric patients (between the ages of 6 and 17 years inclusive at the time of enrollment) with moderately to severely active CD who are prescribed and treated in accordance with the approved local Humira product label under the conditions of routine clinical setting.
To find out the effects of Maralixibat on the treatment of PFIC.
To advance research on Minimal Change Disease (MCD), Focal and Segmental Glomerulosclerosis (FSGS), and Membranous Nephropathy (MN) that define nephrotic syndrome.
A study of glomerular disease patients to better understand the causes of the disease, response to therapy, and disease progression.
To know if stool transplant from a healthy person into an ulcerative colitis patient can help treat the disease.
Safety of Fecal Microbiota Transplantation (FMT) in children with Crohn's disease in remission.
To find out the effects of a chemical in Stevia on the symptoms of NAFLD.
The purpose of the study is to collect information from children 0-18 years of age with all types of pancreatitis to determine the number of children diagnosed with this condition, understand the causes and progression of the disease, and review laboratory and imaging findings as well as responses to any treatments given.
To evaluate the efficacy of tofacitinib based on remission in pediatric participants with moderately to severely active Ulcerative Colitis (UC).